Medical technology company Stryker (NYSE:SYK) reported in Q4 CY2024, with sales up 10.7% year on year to $6.44 billion. Its non-GAAP profit of $4.01 per share was 3.5% above analysts’ consensus ...
Some results have been hidden because they may be inaccessible to you